GTCR Announces Divestiture of Corza Medical's Biosurgery Business Unit to EQT

Positive

AI Analysis

Summary

GTCR announced the divestiture of Corza Medical's Biosurgery business unit to EQT, positioning the unit for growth while Corza Medical continues operations in Wound Closure, Ophthalmology, and Biomedical Textiles.

Outcome Details

GTCR divests Corza Medical's Biosurgery business unit to EQT

Importance:6/10

Sentiment:

0.50

M&Adivestiturebiosurgerysurgical technology

Related Companies

$MDCE

Read the original article

Published by PR Newswire Biotech on July 7, 2026 6:00 AM

Read Original